Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
emerging markets
Pharma
AstraZeneca CEO defends $80B revenue target amid China probes
Concerns over AZ’s large China business escalated in the past few days after senior executives were detained as part of an investigation.
Angus Liu
Nov 12, 2024 9:40am
UPDATED: AstraZeneca stock tanks over fears of more China probe
Nov 5, 2024 3:13pm
Biocon's Peter Bains jumps from the board to group CEO
Sep 19, 2023 9:20am
AZ's China head refutes news report about potential spinoff
Jun 20, 2023 10:20am
CEOs of BioNTech, Bayer, Merck KGaA visit China
Nov 4, 2022 4:20pm
China’s branded drug market to hit $85B in 2030: Jefferies
Mar 21, 2022 1:18pm
